|
|
| | Ertiprotafib Basic information |
| Product Name: | Ertiprotafib | | Synonyms: | Benzenepropanoic acid, a-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-,(aR)-;Ertiprotafib;PTP 112;Benzenepropanoic acid, α-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (αR)- | | CAS: | 251303-04-5 | | MF: | C31H27BrO3S | | MW: | 559.52 | | EINECS: | | | Product Categories: | | | Mol File: | 251303-04-5.mol |  |
| | Ertiprotafib Chemical Properties |
| Boiling point | 690.7±55.0 °C(Predicted) | | density | 1.376±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 3.21±0.10(Predicted) | | color | Light yellow to yellow |
| | Ertiprotafib Usage And Synthesis |
| Uses | Ertiprotafib is an insulin sensitizer developed for treatment of type 2 diabetes. | | Uses | Treatment of non-insulin dependent
diabetes (protein tyrosine phosphatase 1B inhibitor). |
| | Ertiprotafib Preparation Products And Raw materials |
|